Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENLC
5126
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $2.36M | ﹤0.01% |
277,881
-291,232
| -51% | -$2.93M |
|
5127
Acco Brands
ACCO
$401M
| $2.36M | ﹤0.01% |
361,545
+175,638
| +94% | +$1.28M |
|
5128
CALL
RCI Hospitality Holdings
RICK
$236M
| $2.36M | ﹤0.01% |
48,800
-3,600
| -7% | -$207K |
|
5129
CALL
Cedar Fair
FUN
$1.68B
| $2.36M | ﹤0.01% |
53,700
-48,100
| -47% | -$2.33M |
|
5130
CALL
Hubbell
HUBB
$27B
| $2.36M | ﹤0.01% |
13,200
+10,700
| +428% | +$2.02M |
|
5131
PUT
Sphere Entertainment
SPHR
$6.03B
| $2.36M | ﹤0.01% |
44,800
-44,600
| -50% | -$3.01M |
|
|
EDR
5132
CALL
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $2.36M | ﹤0.01% |
114,600
+22,400
| +24% | +$508K |
|
5133
PUT
RUM Group Inc
RUM
$3.7B
| $2.35M | ﹤0.01% |
236,200
-605,100
| -72% | -$6.6M |
|
|
LBAI
5134
CALL
DELISTED
Lakeland Bancorp Inc
LBAI
| $2.35M | ﹤0.01% |
160,900
+72,500
| +82% | +$1.11M |
|
5135
CALL
PAR Technology
PAR
$788M
| $2.35M | ﹤0.01% |
62,700
-13,100
| -17% | -$471K |
|
5136
CALL
LSB Industries
LXU
$737M
| $2.35M | ﹤0.01% |
169,500
+19,500
| +13% | +$389K |
|
5137
CALL
ProShares Short Bitcoin Strategy ETF
BITI
$122M
| $2.35M | ﹤0.01% |
+10,700
| New | +$2.18M |
|
|
TGH
5138
PUT
DELISTED
Textainer Group Holdings limited
TGH
| $2.35M | ﹤0.01% |
85,600
-900
| -1% | -$29.1K |
|
5139
WisdomTree True Developed International Fund
DOL
$847M
| $2.34M | ﹤0.01% |
+56,015
| New | +$2.57M |
|
5140
CALL
Schwab US TIPS ETF
SCHP
$16.2B
| $2.34M | ﹤0.01% |
84,000
+12,000
| +17% | +$348K |
|
|
GRDI
5141
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
| $2.34M | ﹤0.01% |
237,966
-696,743
| -75% | -$6.87M |
|
5142
PUT
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.9M
| $2.34M | ﹤0.01% |
36,300
-3,200
| -8% | -$292K |
|
|
TVRD
5143
Tvardi Therapeutics
TVRD
$25.3M
| $2.34M | ﹤0.01% |
7,106
+1,140
| +19% | +$400K |
|
5144
CALL
Fulcrum Therapeutics
FULC
$285M
| $2.33M | ﹤0.01% |
476,500
+433,500
| +1,008% | +$4.24M |
|
|
IGAC
5145
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
| $2.33M | ﹤0.01% |
235,700
+16,364
| +7% | +$162K |
|
5146
CALL
WEX
WEX
$6.54B
| $2.33M | ﹤0.01% |
15,000
-13,400
| -47% | -$2.19M |
|
|
CIM
5147
CALL
Chimera Investment
CIM
$988M
| $2.33M | ﹤0.01% |
88,133
+52,500
| +147% | +$1.56M |
|
5148
CALL
Elanco Animal Health
ELAN
$11.8B
| $2.33M | ﹤0.01% |
118,800
-29,100
| -20% | -$689K |
|
5149
CALL
LKQ Corp
LKQ
$6.43B
| $2.33M | ﹤0.01% |
47,500
-10,600
| -18% | -$522K |
|
5150
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.17B
| $2.33M | ﹤0.01% |
44,869
+28,809
| +179% | +$1.64M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.